Preoperative CT for postoperative radiotherapy planning in breast cancer
Authors:
A. Hlávka 1,2; J. Štuk 1,2,3; K. Odrážka 1,2,5,6,7; J. Vaňásek 1,4; M. Doležel 5,10,11; M. Vítková 1,2; D. Lášková 1,2; Z. Vilasová 1,4; J. Mergancová 8,9,10; L. Elichová 1; O. Hošek 1,2
Authors‘ workplace:
Multiscan, s. r. o., Pardubice.
1; Oddělení klinické a radiační onkologie, Pardubická nemocnice, Nemocnice Pardubického kraje, a. s., Pardubice.
2; Fakulta vojenského zdravotnictví v Hradci Králové Univerzity obrany v Brně, Brno.
3; Fakulta zdravotnických studií Univerzity Pardubice.
4; 1. lékařská fakulta Univerzity Karlovy, Praha.
5; 3. lékařská fakulta Univerzity Karlovy, Praha.
6; Institut postgraduálního vzdělávání ve zdravotnictví, Praha.
7; Chirurgická klinika, Pardubická nemocnice, Nemocnice Pardubického kraje, a. s., Pardubice.
8; EUC klinika, a. s., Pardubice.
9; Lékařská fakulta Univerzity Palackého, Olomouc.
10; Onkologická klinika Fakultní nemocnice Olomouc
11
Published in:
Rozhl. Chir., 2021, roč. 100, č. 6, s. 278-283.
Category:
Original articles
doi:
https://doi.org/10.33699/PIS.2021.100.6.278–284
Overview
Introduction: The exact location of the original tumor should be known for a targeted increase in the dose to the tumor bed after breast cancer surgery. Therefore, at our site, we perform CT examinations of patients in the radiation position before breast cancer surgery.
Methods: Preoperative native CT scans were performed in the patients in the planning position for radiotherapy; these data were fused with standard planning CT for boost irradiation. We evaluated whether the tumor was accurately identifiable in preoperative CT scans. We also contoured one irradiation volume in the standard planning CT scans and the other in the fusion CT scans with preoperative examination, and compared these volumes.
Results: Out of the total number of 554 patients, we were able to identify the exact location of the breast tumor in 463 cases (83.6 %). In a group of 50 randomly selected patients, the clinical target volume for the boost dose to the postlumpectomy cavity was changed in 20 patients (40%) – decreased in 9 cases (18%) and increased in 11 cases (22%).
Conclusion: As shown by the results of our study, preoperative CT in the planning position can be used in patients with confirmed breast cancer. This method allows us to more accurately locate the tumor bed and thus more accurately draw the target volume for boost irradiation. We confirmed that preoperative CT had an impact on the size of the target volume.
Keywords:
breast cancer − radiation therapy −preoperative CT
Sources
1. Wang L. Early diagnosis of breast cancer. Sensors (Basel) 2017;17:1572. doi:10.3390/s17071572.
2. Taira N, Ohsumi S, Takabatake D, et al. Contrast- enhanced CT evaluation of clinically and mammographically occult multiple breast tumors in women with unilateral early breast cancer. Jpn J Clin Oncol. 2008;38:419–25. doi:10.1093/jjco/hyn040.
3. Glick SJ. Breast CT. Annu Rev Biomed Eng. 2007;9:501–26. doi:10.1146/annurev.bioeng. 9.060906.151924.
4. Hlavka A, Vanasek J, Odrazka K, et al. Tumor bed radiotherapy in women following breast conserving surgery for breast cancer-safety margin with/without image guidance. Oncol Lett. 2018;15:6009– 6014. doi:10.3892/ol.2018.8083.
5. Nakahara H, Namba K, Wakamatsu H, et al. Extension of breast cancer: comparison of CT and MRI. Radiat Med. 2002;20:17–23.
6. Uematsu T. Comparison of magnetic resonance imaging and multidetector computed tomography for evaluating intraductal tumor extension of breast cancer. Jpn J Radiol. 2010;28:563–70. doi:10.1007/s11604-010-0474-5.
7. Ahn SJ, Kim YS, Kim EY, et al. The value of chest CT for prediction of breast tumor size: comparison with pathology measurement. World J Surg Oncol. 2013;11:130. doi:10.1186/1477-7819-11- 130.
8. Boersma LJ, Janssen T, Elkhuizen PHM, et al. Reducing interobserver variation of boost-CTV delineation in breast conserving radiation therapy using a pre-operative CT and delineation guidelines. Radiother Oncol. 2012;103:178–82. doi:10.1016/j.radonc.2011.12.021.
9. Cheng JC-H, Chen CM, Liu MC, et al. Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy. Int J Radiat Oncol Biol Phys. 2002;52:980– 988.
10. Fowble B, Solin LJ, Schultz DJ, et al. Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys. 1990;19:833–842. doi:10.1016/0360-3016(90)90002-2.
11. Haffty BG, Fischer D, Beinfield M, et al. Prognosis following local recurrence in the conservatively treated breast cancer patient. Int J Radiat Oncol Biol Phys. 1991;21:293–298. doi:10.1016/0360- 3016(91)90774-x.
12. Kurtz JM, Amalric R, Brandone H, et al. Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis. Cancer 1989;63:1912–1917. doi:10.1002/1097- 0142(19890515)63:10<1912:aid-cncr2820631007> 3.0.co;2-y.
13. Romestaing P, Lehingue Y, Carrie C, et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol. 1997;15:963–968. doi:10.1200/JCO.1997.15.3.963.
14. Antonini N, Jones H, Horiot JC, et al. Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. Radiother Oncol. 2007;82:265–271. doi:10.1016/j.radonc. 2006.09.014.
15. Dolezel M, Stastny K, Odrazka K, et al. Perioperative interstitial CT-based brachytherapy boost in breast cancer patients with breast conservation after neoadjuvant chemotherapy. Neoplasma 2012;59:494–499. doi:10.4149/ neo_2012_063.
16. Vrieling C, Collette L, Fourquet A, et al. The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC “boost vs. no boost” trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiother Oncol. 2000;55:219– 232. doi: 10.1016/s0167-8140(00)00210- 3.
17. Vrieling C, Collette L, Fourquet A, et al. The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC “boost versus no boost” trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer. Int J Radiat Oncol Biol Phys. 1999;45:677–685. doi:10.1016/s0360- 3016(99)00211-4.
18. Struikmans H, Wárlám-Rodenhuis C, Stam T, et al. Interobserver variability of clinical target volume delineation of glandular breast tissue and of boost volume in tangential breast irradiation. Radiother Oncol. 2005;76:293–299. doi:10.1016/j. radonc.2005.03.029.
19. Coles CE, Wilson CB, Cumming J, et al. Titanium clip placement to allow accurate tumour bed localisation following breast conserving surgery: audit on behalf of the IMPORT Trial Management Group. Eur J Surg Oncol. 2009;35:578–582. doi:10.1016/j.ejso.2008.09.005.
20. Hurkmans C, Admiraal M, van der Sangen M, et al. Significance of breast boost volume changes during radiotherapy in relation to current clinical interobserver variations. Radiother Oncol. 2009;90:60– 65. doi:10.1016/j.radonc.2007.12.001.
21. van Mourik AM, Elkhuizen PHM, Minkema D, et al. Multiinstitutional study on target volume delineation variation in breast radiotherapy in the presence of guidelines. Radiother Oncol. 2010;94:286–291. doi:10.1016/j.radonc.2010.01.009.
22. Kirova YM, Fournier-Bidoz N, Servois V, et al. How to boost the breast tumor bed? A multidisciplinary approach in eight steps. Int J Radiat Oncol Biol Phys. 2008;72:494–500. doi:10.1016/j. ijrobp.2007.12.059.
23. Oh KS, Kong F-M, Griffith KA, et al. Planning the breast tumor bed boost: changes in the excision cavity volume and surgical scar location after breast-conserving surgery and whole-breast irradiation. Int J Radiat Oncol Biol Phys. 2006;66:680–686. doi:10.1016/j.ijrobp.2006.04.042.
24. den Hartogh MD, Philippens MEP, van Dam IE, et al. Post-lumpectomy CT-guided tumor bed delineation for breast boost and partial breast irradiation: Can additional pre- and postoperative imaging reduce interobserver variability? Oncology Letters 2015;10:2795–801. doi:10.3892/ol.2015.3697.
25. Dong Y, Liu Y, Chen J, et al. Comparison of postoperative CT- and preoperative MRI-based breast tumor bed contours in prone position for radiotherapy after breast-conserving surgery. Eur Radiol. 2021 Jan;31(1):345−355. doi:10.1007/ s00330-020-07085-0.
26. den Hartogh MD, Philippens ME, van Dam IE, et al. MRI and CT imaging for preoperative target volume delineation in breast-conserving therapy. Radiat Oncol. 2014;9:63. doi:10.1186/1748-717X-9-63.
Labels
Surgery Orthopaedics Trauma surgeryArticle was published in
Perspectives in Surgery
2021 Issue 6
Most read in this issue
- Iodine seed localisation of non-palpable lesions in breast surgery − first experience
- Appendiceal mucocele – a radiologist’s view
- Phyllodes tumor and its malignization into invasive ductal carcinoma − a case report
- Role of the radiologist during neoadjuvant systemic therapy for breast cancer